USANA HEALTH SCIENCES INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Usana Health Sciences Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Usana Health Sciences Inc Operating Income (Loss) for the quarter ending June 29, 2024 was $17.8M, a 26.9% decline year-over-year.
  • Usana Health Sciences Inc Operating Income (Loss) for the twelve months ending June 29, 2024 was $84.3M, a 12.5% decline year-over-year.
  • Usana Health Sciences Inc annual Operating Income (Loss) for 2023 was $93.1M, a 13.5% decline from 2022.
  • Usana Health Sciences Inc annual Operating Income (Loss) for 2022 was $108M, a 36.8% decline from 2021.
  • Usana Health Sciences Inc annual Operating Income (Loss) for 2021 was $170M, a 3.57% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $84.3M $17.8M -$6.56M -26.9% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $90.9M $24.7M -$2.17M -8.09% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $93.1M $24.2M +$1.67M +7.4% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-27
Q3 2023 $91.4M $17.6M -$5.02M -22.2% Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $96.4M $24.4M -$4.97M -16.9% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 $101M $26.8M -$6.22M -18.8% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 $108M $22.6M -$8.95M -28.4% Oct 2, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $117M $22.6M -$18.1M -44.5% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 $135M $29.4M -$24.4M -45.3% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 $159M $33.1M -$11.1M -25.2% Jan 2, 2022 Apr 2, 2022 10-Q 2023-05-09
Q4 2021 $170M $31.5M -$21M -40% Oct 3, 2021 Jan 1, 2022 10-K 2024-02-27
Q3 2021 $191M $40.8M -$4.59M -10.1% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 $196M $53.7M +$14.1M +35.7% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-09
Q1 2021 $182M $44.2M +$5.19M +13.3% Jan 3, 2021 Apr 3, 2021 10-Q 2022-05-11
Q4 2020 $176M $52.5M +$7.97M +17.9% Sep 27, 2020 Jan 2, 2021 10-K 2023-02-28
Q3 2020 $169M $45.4M +$9.9M +27.9% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-10
Q2 2020 $159M $39.6M +$8.43M +27.1% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $150M $39M +$4.01M +11.5% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-11
Q4 2019 $146M $44.6M -$4M -8.23% Sep 29, 2019 Dec 28, 2019 10-K 2022-03-01
Q3 2019 $150M $35.5M -$10.1M -22.1% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-03
Q2 2019 $160M $31.2M -$20M -39.1% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q1 2019 $180M $35M -$8.13M -18.8% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-05
Q4 2018 $188M $48.6M +$12.7M +35.3% Sep 30, 2018 Dec 29, 2018 10-K 2021-03-02
Q3 2018 $176M $45.5M +$14.2M +45.1% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-05
Q2 2018 $162M $51.1M +$18.8M +58% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $143M $43.1M +$10.2M +31.1% Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $133M $35.9M +$4.06M +12.7% Oct 1, 2017 Dec 30, 2017 10-K 2020-02-25
Q3 2017 $128M $31.4M -$4.48M -12.5% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $133M $32.4M -$5.08M -13.6% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-08
Q1 2017 $138M $32.9M -$617K -1.84% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-09
Q4 2016 $139M $31.8M -$3.3M -9.4% Oct 2, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $142M $35.8M -$2.13M -5.62% Jul 3, 2016 Oct 1, 2016 10-Q 2017-11-08
Q2 2016 $144M $37.4M -$1.32M -3.42% Apr 3, 2016 Jul 2, 2016 10-Q 2017-08-09
Q1 2016 $145M $33.5M +$3.72M +12.5% Jan 3, 2016 Apr 2, 2016 10-Q 2017-05-10
Q4 2015 $142M $35.1M +$2.5M +7.66% Oct 4, 2015 Jan 2, 2016 10-K 2018-02-28
Q3 2015 $139M $38M +$8.71M +29.8% Jul 5, 2015 Oct 3, 2015 10-Q 2016-11-09
Q2 2015 $130M $38.8M +$9.69M +33.3% Apr 5, 2015 Jul 4, 2015 10-Q 2016-08-09
Q1 2015 $121M $29.8M +$4.66M +18.6% Jan 4, 2015 Apr 4, 2015 10-Q 2016-05-11
Q4 2014 $116M $32.6M +$3.63M +12.5% Sep 28, 2014 Jan 3, 2015 10-K 2017-03-01
Q3 2014 $112M $29.3M +$4.56M +18.5% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-12
Q2 2014 $108M $29.1M -$7.37M -20.2% Mar 30, 2014 Jun 28, 2014 10-Q 2015-08-12
Q1 2014 $115M $25.1M -$1.44M -5.42% Dec 29, 2013 Mar 29, 2014 10-Q 2015-05-13
Q4 2013 $117M $29M +$922K +3.28% Sep 29, 2013 Dec 28, 2013 10-K 2016-03-01
Q3 2013 $116M $24.7M +$610K +2.53% Jun 30, 2013 Sep 28, 2013 10-Q 2014-11-06
Q2 2013 $115M $36.5M +$11.3M +44.9% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-05
Q1 2013 $104M $26.6M +$5.7M +27.3% Dec 30, 2012 Mar 30, 2013 10-Q 2014-05-07
Q4 2012 $98.2M $28.1M +$7.98M +39.7% Sep 30, 2012 Dec 29, 2012 10-K 2015-03-17
Q3 2012 $90.2M $24.1M +$5.31M +28.3% Jul 1, 2012 Sep 29, 2012 10-Q 2013-11-07
Q2 2012 $84.9M $25.2M +$4M +18.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $80.9M $20.9M +$3.64M +21.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 $77.3M $20.1M Oct 2, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 $18.8M +$238K +1.28% Jul 3, 2011 Oct 1, 2011 10-Q 2012-11-07
Q2 2011 $21.2M +$4.09M +24% Apr 3, 2011 Jul 2, 2011 10-Q 2012-08-08
Q1 2011 $17.2M Jan 2, 2011 Apr 2, 2011 10-Q 2012-05-10
Q3 2010 $18.5M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-09
Q2 2010 $17.1M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.